Raymond James & Associates’s Invacare Corporation IVC Stock Holding History

Raymond James & Associates’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,000	Closed	-$7.14K	–	4151
2022 Q4	$7.14K	Buy	+17,000	New	+$9.14K	﹤0.01%	3863

Other funds holding IVC

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Raymond James & Associates's IVC Position: Q1 2023 in Review

Raymond James & Associates sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 17,000 shares — an estimated $7.14K sold.

Raymond James & Associates first reported a position in IVC in Q4 2022 and held it in 1 quarter. The position peaked at $7.14K in Q4 2022. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.

Raymond James & Associates reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
Raymond James & Associates sold 17,000 Invacare Corporation shares in Q1 2023, an estimated $7.14K.
Raymond James & Associates first reported a position in Invacare Corporation in Q4 2022 and held it in 1 quarter.
Raymond James & Associates's Invacare Corporation position peaked at $7.14K in Q4 2022.
10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.